» Articles » PMID: 1688652

Detection of P-glycoprotein Isoforms by Gene-specific Monoclonal Antibodies

Overview
Specialty Science
Date 1990 Jan 1
PMID 1688652
Citations 81
Authors
Affiliations
Soon will be listed here.
Abstract

P-glycoprotein is a highly conserved membrane protein shown to be overexpressed in many multidrug-resistant tumor cell lines. P-glycoprotein is encoded by a small gene family in mammalian cells. Class I and II isoforms cause multidrug resistance, whereas class III does not. In this report, we have characterized three P-glycoprotein-specific monoclonal antibodies (mAbs) by high-resolution epitope mapping with a series of hexapeptides. mAb C494 is gene specific, binding to a sequence present only in the class I isoform of hamster and human. The mAb C32 recognizes a sequence conserved in hamster class I and II isoforms but not in class III isoforms. In contrast, the mAb C219 recognizes a highly conserved amino acid sequence found in all P-glycoprotein isoforms characterized to date. These mAbs were used to reveal differential expression and specific localization of the three P-glycoprotein isoforms in hamster tissues by immunohistochemical staining and competition with epitope-specific peptides. Colonic epithelial cells expressed predominantly the class I isoform in a polarized manner, adrenal cortical cells expressed predominantly the class II isoform, whereas a small percentage of skeletal muscle fibers expressed the class III isoform of P-glycoprotein. These findings suggest that the P-glycoprotein isoforms have distinct physiological roles associated with specialized cell functions.

Citing Articles

Progress in characterizing ABC multidrug transporters in zebrafish.

Thomas J, Frye W, Robey R, Gottesman M Drug Resist Updat. 2023; 72:101035.

PMID: 38141369 PMC: 10843779. DOI: 10.1016/j.drup.2023.101035.


The anti-estrogen receptor drug, tamoxifen, is selectively Lethal to P-glycoprotein-expressing Multidrug resistant tumor cells.

Bakadlag R, Limniatis G, Georges G, Georges E BMC Cancer. 2023; 23(1):24.

PMID: 36609245 PMC: 9824978. DOI: 10.1186/s12885-022-10474-x.


ATP-binding cassette transporters at the zebrafish blood-brain barrier and the potential utility of the zebrafish as an model.

Hotz J, Thomas J, Katz E, Robey R, Horibata S, Gottesman M Cancer Drug Resist. 2021; 4:620-633.

PMID: 34308273 PMC: 8297714. DOI: 10.20517/cdr.2021.35.


Natural Products as Alternative Choices for P-Glycoprotein (P-gp) Inhibition.

Dewanjee S, Dua T, Bhattacharjee N, Das A, Gangopadhyay M, Khanra R Molecules. 2017; 22(6).

PMID: 28587082 PMC: 6152721. DOI: 10.3390/molecules22060871.


Inhibition of the Human ABC Efflux Transporters P-gp and BCRP by the BDE-47 Hydroxylated Metabolite 6-OH-BDE-47: Considerations for Human Exposure.

Marchitti S, Mazur C, Dillingham C, Rawat S, Sharma A, Zastre J Toxicol Sci. 2016; 155(1):270-282.

PMID: 28031414 PMC: 6145076. DOI: 10.1093/toxsci/kfw209.


References
1.
Gerlach J, Endicott J, Juranka P, Henderson G, Sarangi F, Deuchars K . Homology between P-glycoprotein and a bacterial haemolysin transport protein suggests a model for multidrug resistance. Nature. 1986; 324(6096):485-9. DOI: 10.1038/324485a0. View

2.
Kartner N, Riordan J, Ling V . Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines. Science. 1983; 221(4617):1285-8. DOI: 10.1126/science.6137059. View

3.
Bell D, Gerlach J, Kartner N, Buick R, Ling V . Detection of P-glycoprotein in ovarian cancer: a molecular marker associated with multidrug resistance. J Clin Oncol. 1985; 3(3):311-5. DOI: 10.1200/JCO.1985.3.3.311. View

4.
Thiebaut F, Tsuruo T, Hamada H, Gottesman M, Pastan I, Willingham M . Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein. J Histochem Cytochem. 1989; 37(2):159-64. DOI: 10.1177/37.2.2463300. View

5.
Geysen H, Rodda S, Mason T, Tribbick G, Schoofs P . Strategies for epitope analysis using peptide synthesis. J Immunol Methods. 1987; 102(2):259-74. DOI: 10.1016/0022-1759(87)90085-8. View